CPhI /P-MEC /ICSE India 2009, South Asia’s biggest and most comprehensive pharmaceutical event, will be held from December 1-3 2009 at the Bombay Exhibition Centre in Mumbai. This most eagerly awaited comprehensive international pharmaceutical event will enable visitors and participants to network and seize business opportunities that can be put into action and prepare you for the next era of growth.
The event has 767 exhibitors from 20 countries & regions with pavilions from CCPIT, CCMHPIE & Pharmexcil. Also featuring at the event will be the P-MEC virtual factory and CPhI technology seminars, presented by the exhibiting companies. The exhibition will witness around 26,000 visitors from 70 plus countries.
Gandhi, Managing Director, UBM India Pvt. Ltd, said, "CPHI India on its 3rd edition has grown to be the largest pharmaceuticals gathering in South Asia, contributing towards the development of India pharma companies both large and SMEs."
Manufacturers of active pharmaceutical ingredients, excipients, natural extracts as well as experts in custom manufacturing will be present at CPhI India. P-MEC India will showcase companies offering pharmaceutical manufacturing technology and solutions. ICSE (The International Contract Service Expo) pavilion is dedicated to the contract services part of the pharmaceutical manufacturing process that will feature exhibitors who are looking at pharmaceutical outsourcing. This year, UBM is proud to introduce BioPh India: Bio-Solutions for Pharma - Hosting such an event alongside established events like CPhI and P-MEC, offers unrivalled networking and commercial opportunities, creating a perfect synergy in the world of drug research and manufacturing.
CPhI / P-MEC / ICSE India 2009, will throw open its doors to the rapidly expanding Indian, South Asian and world pharmaceutical markets, presenting exceptional and countless opportunities in pharmaceutical manufacturing, procurement and new technologies. India’s domestic potential including the untapped rural markets alone, makes it a fascinating market for many in the pharmaceutical industry. Add the explosive economic growth of the region and it becomes obvious why buyers and sellers of pharmaceutical products consider CPhI / P-MEC / ICSE India an event not to be missed.
Concurrent events - The Government of India, Ministry of Chemicals and Fertilisers, Department of Pharmaceuticals, is organising India Pharma Summit 2009, scheduled on November 30, 2009 at Nehru Center, Worli, Mumbai. The Theme of this summit is: - India your partner in Pharma. This Summit will identify opportunities, challenges and create a roadmap to achieve consistent growth. The summit will cover topics like “India Pharma - Status and Opportunities for Production, Investment & Trade,” Opportunities and Challenges in R & D, Clinical Trials, Pharma Education and Industry Academia Partnership” and Vision – “India the Global Partner.”
A Bio-similars India Conference will be taking place alongside CPhI India 2009 at the Bombay Exhibition Centre December 1 and 2. Biosimilars India 2009 consists of 3 halfday conference modules, each designed to provide you with solutions to the strategic issues facing the growing Indian biosimilars market. The conference will cover Biosimilars – Market Opportunities, Regulatory Compliance and Cost effective Production. Hear from an exceptional line-up of leading experts including:- Dr. Arumugam Muruganandam, Senior Scientific Manager, Research & Development, Biocon,Dr. Harvinder Popli, Director and Head In- Licensing, Ranbaxy Labs,Mr. K V Subramaniam, President & CEO, Reliance Life Sciences,Mr. Vijay Kshirsagar, Executive Vice President, Corporate Quality Assurance & Regulatory Affairs, Unichem Laboratories, Dr. Rangarajan Subramanian, Senior Vice President, Quality, Glenmark Generics ,Mr. Dhananjay Patankar, Director, Intas Biopharma.
